HLS Therapeutics to Host Q1 2026 Financial Results Conference Call
HLS Therapeutics to Host Q1 2026 Financial Results Conference Call |
| [01-May-2026] |
TORONTO, May 1, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release financial results for the three months ended March 31, 2026, on Friday, May 15, 2026. The Company will hold a conference call that same day at 10:00 a.m. ET to discuss its results. The call will be hosted by Craig Millian, Chief Executive Officer; John Hanna, Chief Financial Officer; and Brian Walsh, Chief Commercial Officer. Slides to accompany management's prepared remarks will be available via webcast. CONFERENCE ID: 88954 DATE: Friday, May 15, 2026 TIME: 10:00 a.m. ET WEBCAST LINK: https://app.webinar.net/d5b9MbO46zE TRADITIONAL DIAL-IN NUMBER: 1-888-699-1199 or 1-416-945-7677 RAPIDCONNECT: To instantly join the conference call by phone, please use the following URL to easily register and be connected into the conference call automatically: https://emportal.ink/4tMxa8d TAPED REPLAY: 1-888-660-6345 or 1-289-819-1450 REPLAY CODE: 88954# The taped replay will be available for seven days and the archived webcast will be available for 365 days. A link to the live audio webcast and replay of the conference call will also be available on the events page of the investors section of HLS Therapeutics' website at www.hlstherapeutics.com. ABOUT HLS THERAPEUTICS INC. SOURCE HLS Therapeutics Inc. | ||
Company Codes: Toronto:HLS |
